| abstract |
Cancer diagnostic and/or therapeutic and/or prognostic and/or patient stratification biomarker assay for the prognosis and/or diagnosis and/or therapy of colorectal cancer and/or lung cancer and/or pancreatic cancer comprising the combined measurement of fragments of protein biomarkers selected from a first group consisting of: CP; SERPINA3; PON1; optionally in combination with at least one or both protein/peptide biomarkers and/or fragments of protein biomarkers selected from a second group consisting of: IGFBP3; ATRN; LRG1; TIMP1, in human serum, plasma or a derivative of blood, or blood itself and/or of at least two, preferably at least three protein/peptide biomarkers and/or fragments of protein biomarkers selected from the group consisting of: LGALS3BP; PROC; CD163; AOC3 in human serum, plasma or a derivative of blood, or blood itself. |